GlassScriptPhysician profile
Jennifer L Staud
NPI 1760420251
$1,355.44
in general payments reported to CMS, 2019-2025
21 companies · $305 in 2025
The $305 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10.96 · 2021: $16.99 · 2022: $234 · 2023: $570 · 2024: $218 · 2025: $305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,094.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,093.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $249.51 | 2022-2025 | Veozah |
| Myriad Women'S Health, INC. | $155.80 | 2023 | Myrisk |
| Abbvie INC. | $119.86 | 2022-2023 | Lo Loestrin Fe |
| Mayne Pharma Commercial LLC | $87.59 | 2023-2025 | |
| Exeltis, USA INC. | $85.22 | 2023-2025 | Slynd |
| Minerva Surgical, INC | $83.25 | 2023-2024 | |
| Dexcom, INC. | $82.69 | 2023-2025 | Dexcom G6 Transmitter |
| Millicent US INC | $81.72 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Pfizer INC. | $51.16 | 2023-2024 | |
| Meditrina | $49.84 | 2022-2025 | |
| Organon LLC | $46.10 | 2024-2025 | Nexplanon |
| Hologic Sales and Service, LLC | $45.30 | 2022-2024 | Acessa Provu System |
| Shield Therapeutics INC | $40.88 | 2023 | Accrufer |
| Abiomed | $38.08 | 2025 | |
| Avion Pharmaceuticals | $28.08 | 2023 | Balcoltra |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $27.15 | 2024 | V-Loc 180 |
| Ethicon US, LLC | $25.56 | 2025 | Stratafix |
| Agile Therapeutics, INC. | $16.99 | 2021 | |
| Sumitomo Pharma America, INC. | $14.89 | 2023 | Myfembree |
| Insulet Corporation | $14.81 | 2023 | Omnipod |
| Vertical Pharmaceuticals, LLC | $10.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Staud listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.